BioMark Diagnostics (TSE:BUX) has released an update.
BioMark Diagnostics Inc., a company focused on developing early-stage liquid biopsy technologies for cancer detection, welcomes the experienced Theresa Peterson to their advisory team. Peterson’s extensive background includes senior roles at GE Research, expertise in government affairs and securing significant government funding, as well as championing diversity and inclusion within the tech sector. Her appointment is expected to significantly contribute to BioMark’s expansion both in the US and internationally.
For further insights into TSE:BUX stock, check out TipRanks’ Stock Analysis page.
